Estrogen regulation of neurotrophin expression in sympathetic neurons and vascular targets

Brain Research

Volumn 1139, Issue 1, 2007, Pages 6-14

  Kaur, Gurjinder ^a   Janik, James ^a   Isaacson, Lori G ^a   Callahan, Phyllis ^a  

^a MIAMI UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Hormone replacement therapy; Menopause; NGF; SCG

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; NERVE GROWTH FACTOR; NEUROTROPHIN; PLACEBO; PROLACTIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CARDIOVASCULAR FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; EXTERNAL CAROTID ARTERY; FEMALE; GENE EXPRESSION; GENE TARGETING; HEART; HORMONAL REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RAT; REGULATORY MECHANISM; SYMPATHETIC NERVE CELL; VASCULARIZATION; VASODILATATION; WESTERN BLOTTING;

ADRENERGIC FIBERS; ANIMALS; BRAIN; CAROTID ARTERY, EXTERNAL; CEREBRAL ARTERIES; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; NERVE GROWTH FACTOR; NEURONS; OVARIECTOMY; PROLACTIN; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; SUPERIOR CERVICAL GANGLION; TYROSINE 3-MONOOXYGENASE; VASODILATION;

RATTUS;

EID: 33847331543     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.12.084     Document Type: Article

References (69)

1. Akhrass F., Evans A.T., Wang Y., Rich S., Kannan C.R., Fogelfield L., and Mazonne T. Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. J. Clin. Endocrinol. Metab. 88 12 (2003) 5611-5614
2. Anglin J.C., and Brooks V.L. Tyrosine hydroxylase and norepinephrine transporter in sympathetic ganglia of female rats vary with reproductive state. Auton. Neurosci. Basic Clin. 105 (2003) 8-15
3. Barrett-Connor E., and Bush T.L. Estrogen and coronary heart disease in women. JAMA 265 14 (1991) 1861-1867
4. Bierl M.A., Jones E.E., Crutcher K.A., and Isaacson L.G. 'Mature' nerve growth factor is a minor species in most peripheral tissues. Neurosci. Lett. 380 1-2 (2005) 133-137
5. Birkhaeuser M.H. The Women's Health Initiative conundrum. Arch. Women Mental Health 8 1 (2005) 7-14
6. Bjorling D.E., Beckman M., Clayton M.K., and Wang Z.Y. Modulation of nerve growth factor in peripheral organs by estrogen and progesterone. Neuroscience 110 1 (2002) 155-167
7. Blacklock A.D., Johnson M.S., Krizsan-Agbas D., and Smith P.G. Estrogen increases sensory nociceptor neuritogenesis in vitro by a direct, nerve growth factor-independent mechanism. Eur. J. Neurosci. 21 (2005) 2320-2328
8. Booth E.A., Marchesi M., Kilbourne E.J., and Lucchesi B.R. 17 Beta-estradiol as a receptor-mediated cardioprotective agent. J. Pharmacol. Exp. Ther. 307 1 (2003) 395-401
9. Booth E.A., Obeid N.R., and Lucchesi B.R. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am. J. Physiol.: Heart Circ. Physiol. 289 5 (2005) H2039-H2047
10. Brauer M.M., Shockley K.P., Chavez R., Richeri A., Cowen T., and Crutcher K.A. The role of NGF in pregnancy-induced degeneration and regeneration of sympathetic nerves in guinea pig uterus. J. Auton. Nerv. Syst. 79 1 (2000) 19-27
11. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., Horan M.J., and Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 3 (1995) 305-313
12. Chaler C., Richeri A., Viettro L., Chavez-Genaro R., Bianchimano P., and Brauer M.M. Plasticity in developing rat uterine sensory nerves: the role of NGF and TrkA. Cell. Tissue Res. 314 (2003) 191-205
13. Chavez-Genaro R., Crutcher K., Viettro L., Richeri A., Coirolo N., Burnstock G., Cowen T., and Brauer M.M. Differential effects of oestrogen on developing and mature uterine sympathetic nerves. Cell. Tissue Res. 308 (2002) 61-73
14. Cui S., and Goldstein R.S. Expression of estrogen receptors in the dorsal root ganglia of the chick embryo. Brain Res. 882 1-2 (2000) 236-240
15. Dahlberg S.T. Gender difference in the risk factors for sudden cardiac death. Cardiology 77 (1990) 31-40
16. Davies A.M. The role of neurotrophins in the developing nervous system. J. Neurobiol. 25 11 (1994) 1334-1348
17. Du X.J., Riemersma R.A., and Dart A.M. Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function. Cardiovasc. Res. 30 2 (1995) 161-165
18. Dubal D.B., Rau S.W., Shughrue P.J., Zhu Hl., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., and Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERα in estradiol-mediated protection against delayed cell death. Endo 147 (2006) 3076-3084
19. Elkabes S., DiCicco-Bloom E.M., and Black I.B. Brain microglia/macrophages express neurotrophins that selectivelyregulate microglial proliferation and function. J. Neurosci. 16 8 (1996) 2508-2521
20. Fadel P.J., Zhao W., and Thomas G.D. Impaired vasomodulation is associated with reduced neuronal nitric oxide synthase in skeletal muscle of ovariectomized rats. J. Physiol. 549 1 (2003) 243-253
21. Fahnestock M., Michalski B., Xu B., and Coughlin M.D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell Neurosci. 18 2 (2001) 210-220
22. Fait T., Vokrouhlicka J., Vrablik M., and Jenicek J. Present position of the hormonal replacement therapy. Cas. Lek. Ces. 143 7 (2004) 447-452
23. Gibbs R.B. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res. 787 2 (1998) 259-268
24. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., Hsia J., Hulley S., Herd A., Khan S., Newby L.K., Waters D., Vittinghoff E., and Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 288 (2002) 49-57
25. Grodstein F., and Stampfer M.J. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog. Cardiovasc. Dis. 38 3 (1995) 199-210
26. Grodstein F., and Stampfer M.J. Estrogen for women at varying risk of coronary disease. Maturitas 30 1 (1998) 19-26
27. Guo X., Razandi M., Pedram A., Kassab G., and Levin E.R. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J. Biol. Chem. 280 20 (2005) 19704-19710
28. Hasan W., Pedchenko T., Krizsan-Agbas D., Baum L., and Smith P.G. Sympathetic neurons synthesize and secrete pro-nerve growth factor protein. J. Neurobiol. 57 (2003) 38-53
29. Hasan W., Smith H.J., Ting A.Y., and Smith P.G. Estrogen alters TrkA and p75 neurotrophin receptor expression within sympathetic neurons. J. Neurobiol. 65 (2005) 192-204
30. He X.R., Wang W., Crofton J.T., and Share L. Effects of 17 beta-estradiol onsympathetic activity and pressor response to phenylephrine in ovariectomized rats. Am. J. Physiol. 275 4 Pt 2 (1998) R1202-R1208
31. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., and Collins P.A. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br. J. Pharmacol. 104 4 (1991) 1033-1037
32. Jun C.D., Pae H.O., Yoo J.C., Kwak H.J., Park R.K., and Chung H.T. Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemic HL-60 cells. Cell. Immunol. 183 1 (1998) 13-21
33. Krizsan-Agbas D., Pedchenko T., Hasan W., and Smith P.G. Oestrogen regulates sympathetic neurite outgrowth by modulating brain derived neurotrophic factor synthesis and release by the rodent uterus. Eur. J. Neurosci. 18 10 (2003) 2760-2768
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
35. Lantin-Hermoso R.L., Rosenfield C.R., Yuhana I.S., German Z., Chen Z., and Shaul P.W. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am. J. Physiol. 273 1 Pt 1 (1997) L119-L126
36. Lloyd T., and Weisz J. Direct inhibition of tyrosine hydroxylase activity by catechol estrogens. J. Biol. Chem. 253 14 (1978) 4841-4843
37. Longo F.M., Martignetti J.A., Le Beau J.M., Zhang J.S., Barnes J.P., and Brosius J. Leukocyte common antigen-related receptor-linked tyrosine phosphatase: regulation of mRNA expression. J. Biol. Chem. 268 35 (1993) 26503-26511
38. Lydrup M.L., and Ferno M. Correlation between estrogen receptor alpha expression, collagen content and stiffness in human uterine arteries. Acta Obstet. Gynecol. Scand. 82 7 (2003) 610-615
39. Maharajan S., Serova L., and Sabban E.L. Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP. J. Neurochem. 93 (2005) 1502-1514
40. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am. J. Cardiol. 89 (2002) 12E-18E (Suppl.)
41. Mendelsohn M.E. Genomic and nongenomic effects of estrogen in the vasculature. Am. J. Cardiol. 90 (2002) 3F-6F (Suppl.)
42. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 23 (1999) 1801-1811
43. Mohamed M.K., El-Mas M.M., and Abdel-Rehman A.A. Estrogen enhancement of baroreflex sensitivity is centrally mediated. Am. J. Physiol. 276 4 Pt 2 (1999) R1030-R1037
44. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A.A., Howard B.V., Johnson K.C., Kotchen J.M., and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
45. Saleh T.M., and Connell B.J. Role of 17 beta-estradiol in the modulation of baroreflex sensitivity in male rats. Am. J. Physiol. 275 3 Pt 2 (1998) R770-R778
46. Serova L., Maharajan S., Huang A., Sun D., Kaley G., and Sabban E. Response of tyrosine hydroxylase and GTP cyclohydrolase I gene expression to estrogen in brain catecholaminergic regions varies with mode of administration. Brain Res. 1015 (2004) 1-8
47. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., and Coker L.H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's health initiative memory study. JAMA 291 (2004) 2947-2958
48. Sohrabji F., Green L.A., Miranda R.C., and Toran-Allerand C.D. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J. Neurobiol. 25 8 (1994) 974-988
49. Sohrabji F., Miranda R.C., and Toran-Allerand C.D. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J. Neurosci. 14 2 (1994) 459-471
50. Sudhir K., Chou T.M., Mullen W.L., Hausmann D., P.Collins P., Yock P.G., and Chatterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol. 26 3 (1995) 807-814
51. Tamamaki N., and Nojyo Y. Intracranial trajectories of sympathetic nerve fibers originating in the superior cervical ganglion in the rat: WGA-HRP anterograde labeling study. Brain Res. 437 2 (1987) 387-392
52. Toran-Allerand C.D. Mechanisms of estrogen action during neural development: mediation by interactions with the neurotrophins and their receptors?. J. Steroid. Biochem. Mol. Biol. 56 (1996) 169-178
53. Toran-Allerand C.D., Miranda R.C., Bentham W.D., Sohrabji F., Brown T.J., Hochberg R.B., and MacLusky N.J. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. U. S. A. 89 10 (1992) 4668-4672
54. Tsuda M., Iwai M., Li J., Li H., Min L., Ide A., Okumura M., Suzuki J., Mogi M., Suzuki H., and Horiuchi M. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension 45 4 (2005) 545-551
55. van der Schouw Y.T., van der Graaf Y., Steyerberg E.W., Eijkemans J.C., and Banga J.D. Age at menopause as a risk factor for cardiovascular mortality. Lancet 347 9003 (1996) 714-718
56. Varol F.G., Duchemin A.M., Neff N.H., and Hadjiconstantinou M. Nerve growth factor (NGF) and NGF mRNA change in rat uterus during pregnancy. Neurosci. Lett. 294 1 (2000) 58-62
57. Volterrani M., Rosano G., Coats A., Beale C., and Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am. J. Med. 99 2 (1995) 119-122
58. Voulteenaho O., and Ruskoaho H. Gender matters: estrogen protects from cardiac hypertrophy. Trends Endocrinol. Metab. 14 2 (2003) 52-54
59. Wassertheil-Smoller S., Hendrix S.L., Limacher M., Heiss G., Kooperberg C., Baird A., Kotchen T., Curb J.D., Black H., Rossouw J.E., Aragaki A., Safford M., Stein E., Laowattana S., and Mysiw W.J. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: a randomized trial. JAMA 289 (2003) 2673-2684
60. Wise P. Estradiol exerts neuroprotective actions against ischemic brain injury: insights derived from animal models. Endocrine 21 1 (2003) 11-15
61. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., and Bottner M. Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endo 142 3 (2001) 969-973
62. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M., and Rosewell K.L. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res. Rev. 37 1-3 (2001) 313-319
63. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., and Liu Y. Estrogens: trophic and protective factors in the adult brain. Front. Neuroendocrinol. 22 1 (2001) 33-66
64. Wise P.M., Dubal D.B., Rau S.W., Brown C.M., and Suzuki S. Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's Health Initiative. Endocr. Rev. 26 (2005) 308-312
65. Zhou X.F., Zettler C., and Rush R.A. An improved procedure for the immunohistochemical localization of nerve growth factor-like immunoreactivity. J. Neurosci. Methods 54 (1994) 95-102
66. Zoubina E.V., and Smith P.G. Sympathetic hyperinnervation of the uterus in the estrogen receptor alpha knock-out mouse. Neurosceince 103 (2001) 237-244
67. Zoubina E.V., and Smith P.G. Distributions of estrogen receptors alpha and beta in sympathetic neurons of female rats: enriched expression by uterine innervation. J. Neurobiol. 52 (2002) 14-23
68. Zoubina E.V., and Smith P.G. Expression of estrogen receptors alpha and beta by sympathetic ganglion neurons projecting to the proximal urethra of female rats. J. Urol. 169 1 (2003) 382-385
69. Zoubina E.V., Mize A.L., Alper R.H., and Smith P.G. Acute and chronic oestrogen supplementation decreases uterine sympathetic innervation in ovariectomised adult virgin rats. Histol. Histopathol. 16 (2001) 989-996